|
1
|
Fletcher CDM, Unni KK and Mertens F: World
Health Organization Classification of Tumours: Pathology and
Genetics of Tumours of Soft Tissue and Bone. IARC Press; Lyon,
France: 2002
|
|
2
|
Bridge JA and Cushman-Vokoun AM: Molecular
diagnostics of soft tissue tumors. Arch Pathol Lab Med.
135:588–601. 2011.PubMed/NCBI
|
|
3
|
Weiss SW and Goldblum JR: Enzinger and
Weiss’s: Soft Tissue Tumors. Mosby; Philadelphia: 2008
|
|
4
|
Sawyer JR, Sammartino G, Baker GF and Bell
JM: Clonal chromosome aberrations in a case of nodular fasciitis.
Cancer Genet Cytogenet. 76:154–156. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Birdsall SH, Shipley JM, Summersgill BM,
et al: Cytogenetic findings in a case of nodular fasciitis of the
breast. Cancer Genet Cytogenet. 81:166–168. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Weibolt VM, Buresh CJ, Roberts CA, et al:
Involvement of 3q21 in nodular fasciitis. Cancer Genet Cytogenet.
106:177–179. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Donner LR, Silva T and Dobin SM: Clonal
rearrangement of 15p11.2, 16p11.2 and 16p13.3 in a case of nodular
fasciitis: additional evidence favoring nodular fasciitis as a
benign neoplasm and not a reactive tumefaction. Cancer Genet
Cytogenet. 139:138–140. 2002. View Article : Google Scholar
|
|
8
|
Velagaleti GVN, Tapper JK, Panova NE,
Miettinen M and Gatalica Z: Cytogenetic findings in a case of
nodular fasciitis of subclavicular region. Cancer Genet Cytogenet.
141:160–163. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Meng GZ, Zhang HY, Zhang Z, Wei B and Bu
H: Myofibroblastic sarcoma vs nodular fasciitis: a comparative
study of chromosomal imbalances. Am J Clin Pathol. 131:701–709.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bacac M, Migliavacca E, Stehle JC, et al:
A gene expression signature that distinguishes desmoid tumours from
nodular fasciitis. J Pathol. 208:543–553. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Erickson-Johnson MR, Chou MM, Evers BR, et
al: Nodular fasciitis: a novel model of transient neoplasia induced
by MYH9-USP6 gene fusion. Lab Invest. 91:1427–1433. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Oliveira AM, Hsi BL, Weremowicz S, et al:
USP6 (Tre2) fusion oncogenes in aneurysmal bone cyst. Cancer Res.
64:1920–1923. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sukov WR, Franco MF, Erickson-Johnson M,
et al: Frequency of USP6 rearrangements in myositis ossificans,
brown tumor and cherubism: molecular cytogenetic evidence that a
subset of ‘myositis ossificans-like lesions’ are the early phases
in the formation of soft-tissue aneurysmal bone cyst. Skeletal
Radiol. 37:321–327. 2008.PubMed/NCBI
|
|
14
|
Thway K, Flora RS and Fisher C: Chondroid
lipoma: an update and review. Ann Diagn Pathol. 16:230–234. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nishio J: Contributions of cytogenetics
and molecular cytogenetics to the diagnosis of adipocytic tumors. J
Biomed Biotechnol 2011. 5240672011.PubMed/NCBI
|
|
16
|
Nishio J, Iwasaki H, Nabeshima K and Naito
M: Cytogenetics and molecular genetics of myxoid soft-tissue
sarcomas. Genet Res Int. 2011:4971482011.PubMed/NCBI
|
|
17
|
Gisselsson D, Domanski HA, Höglund M, et
al: Unique cytological features and chromosome aberrations in
chondroid lipoma: a case report based on fine-needle aspiration
cytology, histopathology, electron microscopy, chromosome banding
and molecular cytogenetics. Am J Surg Pathol. 23:1300–1304. 1999.
View Article : Google Scholar
|
|
18
|
Thomson TA, Horsman D and Bainbridge TC:
Cytogenetic and cytologic features of chondroid lipoma of soft
tissue. Mod Pathol. 12:88–91. 1999.PubMed/NCBI
|
|
19
|
Ballaux F, Debiec-Rychter M, De Wever I
and Sciot R: Chondroid lipoma is characterized by
t(11;16)(q13;p12–13). Virchows Arch. 444:208–210. 2004.PubMed/NCBI
|
|
20
|
Huang D, Sumegi J, Dal Cin P, et al:
C11orf95-MKL2 is the resulting fusion oncogene of t(11;16)(q13;p13)
in chondroid lipoma. Genes Chromosomes Cancer. 49:810–818.
2010.PubMed/NCBI
|
|
21
|
Evans HL: Desmoplastic fibroblastoma: a
report of seven cases. Am J Surg Pathol. 19:1077–1081. 1995.
View Article : Google Scholar
|
|
22
|
Magro G and Venti C: Childhood
desmoplastic fibroblastoma (collagenous fibroma) with a 12-year
follow-up. Pediatr Dev Pathol. 2:62–64. 1999.PubMed/NCBI
|
|
23
|
Nishio J, Iwasaki H, Nishijima T and
Kikuchi M: Collagenous fibroma (desmoplastic fibroblastoma) of the
finger in a child. Pathol Int. 52:322–325. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sciot R, Samson I, Van Den Berghe H, Van
Damme B and Dal Cin P: Collagenous fibroma (desmoplastic
fibroblastoma): genetic link with fibroma of tendon sheath? Mod
Pathol. 12:565–568. 1999.PubMed/NCBI
|
|
25
|
Bernal K, Nelson M, Neff JR, Nielsen SM
and Bridge JA: Translocation (2;11)(q31;q12) is recurrent in
collagenous fibroma (desmoplastic fibroblastoma). Cancer Genet
Cytogenet. 149:161–163. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sakamoto A, Yamamoto H, Yoshida T, et al:
Desmoplastic fibroblastoma (collagenous fibroma) with a specific
breakpoint of 11q12. Histopathology. 51:859–860. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Maghari A, Ma N, Aisner S, Benevenia J and
Hameed M: Collagenous fibroma (desmoplastic fibroblastoma) with a
new translocation involving 11q12: a case report. Cancer Genet
Cytogenet. 192:73–75. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nishio J, Akiho S, Iwasaki H and Naito M:
Translocation t(2;11) is characteristic of collagenous fibroma
(desmoplastic fibroblastoma). Cancer Genet. 204:569–571. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Macchia G, Trombetta D, Möller E, et al:
FOSL1 as a candidate target gene for 11q12 rearrangements in
desmoplastic fibroblastoma. Lab Invest. 92:735–743. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dal Cin P, Sciot R, De Smet L and Van Den
Berghe H: Translocation 2;11 in a fibroma of tendon sheath.
Histopathology. 32:433–435. 1998.PubMed/NCBI
|
|
31
|
Young MR and Colburn NH: Fra-1 a target
for cancer prevention or intervention. Gene. 379:1–11. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ray RA, Morton CC, Lipinski KK, Corson JM
and Fletcher JA: Cytogenetic evidence of clonality in a case of
pigmented villonodular synovitis. Cancer. 67:121–125. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Fletcher JA, Henkle C, Atkins L, Rosenberg
AE and Morton CC: Trisomy 5 and trisomy 7 are nonrandom aberrations
in pigmented villonodular synovitis: confirmation of trisomy 7 in
uncultured cells. Genes Chromosomes Cancer. 4:264–266. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mertens F, Orndal C, Mandahl N, et al:
Chromosome aberrations in tenosynovial giant cell tumors and
nontumorous synovial tissue. Genes Chromosomes Cancer. 6:212–217.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Rowlands CG, Roland B, Hwang WS and Sevick
RJ: Diffusevariant tenosynovial giant cell tumor: a rare and
aggressive lesion. Hum Pathol. 25:423–425. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Dal Cin P, Sciot R, Samson I, et al:
Cytogenetic characterization of tenosynovial giant cell tumors
(nodular tenosynovitis). Cancer Res. 54:3986–3987. 1994.
|
|
37
|
Choong PF, Willen H, Nilbert M, et al:
Pigmented villonodular synovitis. Monoclonality and metastasis - a
case for neoplastic origin? Acta Orthop Scand. 66:64–68. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Gonzalez-Campora R, Salas Herrero E,
Otal-Salaverri C, et al: Diffuse tenosynovial giant cell tumor of
soft tissues: report of a case with cytologic and cytogenetic
findings. Acta Cytol. 39:770–776. 1995.PubMed/NCBI
|
|
39
|
Dal Cin P, Sciot R, De Smet L, Van Damme B
and Van Den Berghe H: A new cytogenetic subgroup in tenosynovial
giant cell tumors (nodular tenosynovitis) is characterized by
involvement of 16q24. Cancer Genet Cytogenet. 87:85–87.
1996.PubMed/NCBI
|
|
40
|
Ohjimi Y, Iwasaki H, Ishiguro M, et al:
Short arm of chromosome 1 aberration recurrently found in pigmented
villonodular synovitis. Cancer Genet Cytogenet. 90:80–85. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Sciot R, Rosai J, Dal Cin P, et al:
Analysis of 35 cases of localized and diffuse tenosynovial giant
cell tumor: a report from the chromosomes and morphology (CHAMP)
study group. Mod Pathol. 12:576–579. 1999.PubMed/NCBI
|
|
42
|
Nilsson M, Hoglund M, Panagopoulos I, et
al: Molecular cytogenetic mapping of recurrent chromosomal
breakpoints in tenosynovial giant cell tumors. Virchows Arch.
441:475–480. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ferrer J, Namiq A, Carda C, Lopez-Gines C,
Tawfik O and Llombart-Bosch A: Diffuse type of giant-cell tumor of
tendon sheath: an ultrastructural study of two cases with
cytogenetic support. Ultrastruct Pathol. 26:15–21. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Brandal P, Bjerkehagen B and Heim S:
Molecular cytogenetic characterization of tenosynovial giant cell
tumors. Neoplasia. 6:578–583. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Occhipinti E, Heinrich SD and Craver R:
Giant cell tumor of tendon sheath arising in the toe. Fetal Pediatr
Pathol. 23:171–179. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
West RB, Rubin BP, Miller MA, et al: A
landscape effect in tenosynovial giant-cell tumor from activation
of CSF1 expression by a translocation in a minority of tumor cells.
Proc Natl Acad Sci USA. 103:690–695. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Moller E, Mandahl N, Mertens F and
Panagopoulos I: Molecular identification of COL6A3-CSF1 fusion
transcripts in tenosynovial giant cell tumors. Genes Chromosomes
Cancer. 47:21–25. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Blay JY, El Sayadi H, Thiesse P, Garret J
and Ray-Coquard I: Complete response to imatinib in relapsing
pigmented villonodular synovitis/tenosynovial giant cell tumor
(PVNS/TGCT). Ann Oncol. 19:821–822. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Cassier PA, Gelderblom H, Stacchiotti S,
et al: Efficacy of imatinib mesylate for the treatment of locally
advanced and/or metastatic tenosynovial giant cell tumor/pigmented
villonodular synovitis. Cancer. 118:1649–1655. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Mariño-Enríquez A and Fletcher CDM:
Angiofibroma of soft tissue: clinicopathologic characterization of
a distinctive benign fibrovascular neoplasm in a series of 37
cases. Am J Surg Pathol. 36:500–508. 2012.PubMed/NCBI
|
|
51
|
Jin Y, Möller E, Nord KH, et al: Fusion of
the AHRR and NCOA2 genes through a recurrent translocation
t(5;8)(p15;q13) in soft tissue angiofibroma results in upregulation
of aryl hydrocarbon receptor target genes. Genes Chromosomes
Cancer. 51:510–520. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Schoolmeester JK, Sukov WR, Aubry MC and
Folpe AL: Angiofibroma of soft tissue: core needle biopsy
diagnosis, with cytogenetic confirmation. Am J Surg Pathol.
36:1421–1423. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Sumegi J, Streblow R, Frayer RW, et al:
Recurrent t(2;2) and t(2;8) translocations in rhabdomyosarcoma
without the canonical PAX-FOXO1 fuse PAX3 to members of the nuclear
receptor transcriptional coactivator family. Genes Chromosomes
Cancer. 49:224–236. 2010.
|
|
54
|
Wang L, Motoi T, Khanin R, et al:
Identification of a novel, recurrent HEY1-NCOA2 fusion in
mesenchymal chondrosarcoma based on a genome-wide screen of
exon-level expression data. Genes Chromosomes Cancer. 51:127–139.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Montgomery EA, Devaney KO, Giordano TJ and
Weiss SW: Inflammatory myxohyaline tumor of distal extremities with
virocyte or Reed-Sternberg-like cells: a distinctive lesion with
features simulating inflammatory conditions, Hodgkin’s disease and
various sarcomas. Mod Pathol. 11:384–391. 1998.
|
|
56
|
Meis-Kindblom JM and Kindblom LG: Acral
myxoinflammatory fibroblastic sarcoma: a low-grade tumor of the
hands and feet. Am J Surg Pathol. 22:911–924. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Lambert I, Debiec-Rychter M, Guelinckx P,
Hagemeijer A and Sciot R: Acral myxoinflammatory fibroblastic
sarcoma with unique clonal chromosomal changes. Virchows Arch.
438:509–512. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Mansoor A, Fidda N, Himoe E, Payne M,
Lawce H and Magenis RE: Myxoinflammatory fibroblastic sarcoma with
complex supernumerary ring chromosomes composed of chromosome 3
segments. Cancer Genet Cytogenet. 152:61–65. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Ida CM, Rolig KA, Hulshizer RL, et al:
Myxoinflammatory fibroblastic sarcoma showing t(2;6)(q31;p21.3) as
a sole cytogenetic abnormality. Cancer Genet Cytogenet.
177:139–142. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Gonzalez-Cámpora R, Ríos-Martín JJ,
Solórzano-Amoretti A, et al: Fine needle aspiration cytology of an
acral myxoinflammatory fibroblastic sarcoma: case report with
cytological and cytogenetic findings. Cytopathology. 19:118–123.
2008.PubMed/NCBI
|
|
61
|
Hallor KH, Sciot R, Staaf J, et al: Two
genetic pathways, t(1;10) and amplification of 3p11–12, in
myxoinflammatory fibroblastic sarcoma, haemosiderotic
fibrolipomatous tumour and morphologically similar lesions. J
Pathol. 217:716–727. 2009.PubMed/NCBI
|
|
62
|
Elco CP, Mariño-Enríquez A, Abraham JA,
Dal Cin P and Hornick JL: Hybrid myxoinflammatory fibroblastic
sarcoma/hemosiderotic fibrolipomatous tumor: report of a case
providing further evidence for a pathogenetic link. Am J Surg
Pathol. 34:1723–1727. 2010.
|
|
63
|
Antonescu CR, Zhang L, Nielsen GP,
Rosenberg AE, Dal Cin P and Fletcher CD: Consistent t(1;10) with
rearrangements of TGFBR3 and MGEA5 in both myxoinflammatory
fibroblastic sarcoma and hemosiderotic fibrolipomatous tumor. Genes
Chromosomes Cancer. 50:757–764. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Wettach GR, Boyd LJ, Lawce HJ, Magenis RE
and Mansoor A: Cytogenetic analysis of a hemosiderotic
fibrolipomatous tumor. Cancer Genet Cytogenet. 182:140–143. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Baumhoer D, Glatz K, Schulten HJ, et al:
Myxoinflammatory fibroblastic sarcoma: investigations by
comparative genomic hybridization of two cases and review of the
literature. Virchows Arch. 451:923–928. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Hélias-Rodzewicz Z, Pérot G, Chibon F, et
al: YAP1 and VGLL3, encoding two cofactors of TEAD transcription
factors, are amplified and overexpressed in a subset of soft tissue
sarcomas. Genes Chromosomes Cancer. 49:1161–1171. 2010.PubMed/NCBI
|
|
67
|
Mattila MM and Härkönen PL: Role of
fibroblast growth factor 8 in growth and progression of hormonal
cancer. Cytokine Growth Factor Rev. 18:257–266. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Folpe AL and Weiss SW: Ossifying
fibromyxoid tumor of soft parts: a clinicopathologic study of 70
cases with emphasis on atypical and malignant variants. Am J Surg
Pathol. 27:421–431. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Miettinen M, Finnell V and Fetsch JF:
Ossifying fibromyxoid tumor of soft parts - a clinicopathologic and
immunohistochemical study of 104 cases with long-term follow-up and
a critical review of the literature. Am J Surg Pathol. 32:996–1005.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Graham RP, Dry S, Li X, et al: Ossifying
fibromyxoid tumor of soft parts: a clinicopathologic, proteomic and
genomic study. Am J Surg Pathol. 35:1615–1625. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Sovani V, Velagaleti GVN, Filipowicz E,
Gatalica Z and Knisely AS: Ossifying fibromyxoid tumor of soft
parts: report of a case with novel cytogenetic findings. Cancer
Genet Cytogenet. 127:1–6. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Nishio J, Iwasaki H, Ohjimi Y, et al:
Ossifying fibromyxoid tumor of soft parts: cytogenetic findings.
Cancer Genet Cytogenet. 133:124–128. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Kawashima H, Ogose A, Umezu H, et al:
Ossifying fibromyxoid tumor of soft parts with clonal chromosomal
aberrations. Cancer Genet Cytogenet. 176:156–160. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Gebre-Medhin S, Nord KH, Möller E, et al:
Recurrent rearrangement of the PHF1 gene in ossifying fibromyxoid
tumors. Am J Pathol. 181:1069–1077. 2012. View Article : Google Scholar : PubMed/NCBI
|
